Prognostic and predictive biomarkers with therapeutic targets in breast cancer: A 2022 update on current developments, evidence, and recommendations.

Chung, Clement; Yeung, Vanessa T Y; Wong, Kenneth C W

Chung, Clement; Yeung, Vanessa T Y; Wong, Kenneth C W.

Afiliación

Chung C; Department of Pharmacy, Houston Methodist West Hospital, Houston, TX, USA.
Yeung VTY; State Key Laboratory of Translational Oncology, Sir YK Pao Centre for Cancer, Department of Clinical Oncology, Hong Kong Cancer Institute, The Chinese University of Hong Kong, Hong Kong SAR.
Wong KCW; State Key Laboratory of Translational Oncology, Sir YK Pao Centre for Cancer, Department of Clinical Oncology, Hong Kong Cancer Institute, The Chinese University of Hong Kong, Hong Kong SAR.

J Oncol Pharm Pract ; 29(6): 1343-1360, 2023 Sep.

Article en En | MEDLINE | ID: mdl-35971313

Asunto(s)

Neoplasias de la Mama; Humanos; Femenino; Pronóstico; Neoplasias de la Mama/genética; Proteína BRCA1/genética; Inestabilidad de Microsatélites; Biomarcadores de Tumor/genética; Biomarcadores de Tumor/metabolismo; Proteína BRCA2/genética

Palabras clave

biomarkers; breast cancer; immune cancer therapy; predictive or prognostic; targeted therapy

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama Tipo de estudio: Guideline / Prognostic_studies / Risk_factors_studies Límite: Female / Humans Idioma: En Revista: J Oncol Pharm Pract Asunto de la revista: FARMACIA Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google